New 2,4-diaryl-3-azabicyclo[3.3.1]nonan-9-one derivatives as antimicrobial and anti-cancer agents: Synthesis, in-vitro and SAR studies

化学 抗菌剂 苯甲醛 立体化学 醋酸铵 碳-13核磁共振 亚胺 核化学 药物化学 有机化学 高效液相色谱法 催化作用
作者
Farid M. Sroor,Abdelmageed M. Othman,Khaled Mahmoud,Karima F. Mahrous
出处
期刊:Journal of Molecular Structure [Elsevier]
卷期号:1294: 136516-136516 被引量:4
标识
DOI:10.1016/j.molstruc.2023.136516
摘要

A new series of biologically active 2,4-diphenyl-N-(4-(thiophen-2-yl)thiazol-2-yl)-3-azabicyclo[3.3.1]nonan-9-imine and N-(4-(naphthalen-2-yl)thiazol-2-yl)-2,4-diphenyl-3-azabicyclo[3.3.1]nonan-9-imine derivatives 11–18 were synthesized by reaction of the corresponding 2,4-diphenyl-3-azabicyclo[3.3.1]nonan-9-ones 7–10 with the newly synthesized 2-aminothiazoles 3 and 4. Compounds 7–10 were conveniently synthesized via eco-friendly double Mannich condensation of cyclohexanone (1 equivalent), benzaldehyde derivatives (2 equivalents) and ammonium acetate (1.5 equivalent) in the presence of DMAP (0.5 equivalent). The newly prepared compounds were fully characterized by spectral techniques such as FT-IR, 1H NMR, 13C NMR and elemental analysis. Compounds 11–18 were evaluated in vitro as antimicrobial and anti-cancer agents. Compounds 14 and 17 exerted the highest antimicrobial activity among the other tested compounds, showing the maximum action against Bacillus mycoides (27 and 25 mm, respectively). Additionally, compound 14 showed a minimum inhibition concentration (MIC) value lower than 0.0195 mg/mL against B. mycoides, whereas both compounds (14 and 17) were able to inhibit the growth of Candida albicans at MIC value of 0.0781 mg/ml. Compounds 11, 13 and 18 showed the best cytotoxic activity against A549 cell line (IC50 = 61.20, 57.00 and 17.54 µM, respectively) compared to doxorubicin with IC50 = 52.06 µM. Compounds 11 and 14 showed the best cytotoxic activity against HePG2 cell line (IC50 = 28.97 and 27.69 µM, respectively) compared to doxorubicin with IC50 = 39.74 µM. Expression analysis of liver cancer for compound 14 related to Hexokinase 2 (HK2) and Glutamate-Ammonia Ligase (GLUL) genes was used in HepG2 using RT-qPCR. The negative control of lung and liver cancer cell lines showed a significant increase (p < 0.01) in gene expressions of the CDH1 and IGSF3 compared to the treated cell lines (13, 18 and positive control). Also, the expression of the investigated liver cancer markers in treated (14) and positive control cells was significantly (p < 0.05) lower than their expression in the negative control cells. Gene expression analysis for compound 18 was investigated against lung cancer cell lines using related genes namely, P53, CDK4, BAX, Bcl2 genes. In addition, flow cytometric analysis of apoptosis was studied in 18 treated A549 cell lines.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
2秒前
2秒前
哈嘻嘻完成签到,获得积分10
3秒前
高lucky发布了新的文献求助10
4秒前
4秒前
4秒前
5秒前
hhydeppt完成签到,获得积分10
5秒前
5秒前
M1982完成签到,获得积分10
6秒前
共享精神应助坚强的严青采纳,获得10
6秒前
gz发布了新的文献求助10
8秒前
李麟发布了新的文献求助10
8秒前
江岸与城完成签到 ,获得积分10
9秒前
M1982发布了新的文献求助10
9秒前
11秒前
lannal完成签到,获得积分10
11秒前
JamesPei应助烟雨采纳,获得10
11秒前
12秒前
13秒前
14秒前
15秒前
丸子完成签到,获得积分20
15秒前
肘子发布了新的文献求助10
16秒前
17秒前
ywq发布了新的文献求助10
17秒前
gz完成签到,获得积分10
17秒前
Feeee完成签到,获得积分10
17秒前
17秒前
18秒前
18秒前
yuze发布了新的文献求助20
19秒前
狂野电源关注了科研通微信公众号
20秒前
kingjames发布了新的文献求助10
20秒前
111发布了新的文献求助10
21秒前
研友_852G6L完成签到,获得积分10
22秒前
顾矜应助飞快的小懒虫采纳,获得10
23秒前
Zoom发布了新的文献求助10
24秒前
于冬雪完成签到 ,获得积分10
24秒前
高分求助中
The Oxford Handbook of Social Cognition (Second Edition, 2024) 1050
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
Chen Hansheng: China’s Last Romantic Revolutionary 500
COSMETIC DERMATOLOGY & SKINCARE PRACTICE 388
Case Research: The Case Writing Process 300
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3141752
求助须知:如何正确求助?哪些是违规求助? 2792710
关于积分的说明 7803941
捐赠科研通 2448986
什么是DOI,文献DOI怎么找? 1303011
科研通“疑难数据库(出版商)”最低求助积分说明 626717
版权声明 601244